abstract |
The invention relates to the use of substituted 4-amino-1-phenylbutan-2-ol compounds in the form of their racemates, enantiomers, diastereomers or corresponding bases or corresponding salts of physiologically acceptable aci ds as regulators for the nociceptin/orphanin-FQ ligand ORL1 receptor system and for the production of medicaments. |